Patents by Inventor Flemming Seier Nielsen

Flemming Seier Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230302092
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: April 4, 2023
    Publication date: September 28, 2023
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • Publication number: 20220313786
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: June 3, 2022
    Publication date: October 6, 2022
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • Patent number: 11382957
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: July 12, 2022
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • Publication number: 20210275458
    Abstract: The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
    Type: Application
    Filed: May 14, 2021
    Publication date: September 9, 2021
    Inventors: Simon Bjerregaard, Per Sauerberg, Flemming Seier Nielsen, Betty Lomstein Pedersen, Erik Skibsted
  • Publication number: 20210177944
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: February 19, 2021
    Publication date: June 17, 2021
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • Patent number: 10960052
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: March 30, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • Patent number: 9278123
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Grant
    Filed: December 16, 2011
    Date of Patent: March 8, 2016
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen
  • Publication number: 20150141336
    Abstract: The invention relates to novel use of Pancreatic Polypeptides as well as novel Pancreatic Polypeptides and compositions thereof. Such peptides can be used in treating or preventing conditions responsive to Y4 and/or Y5 receptor activation, such as cachexia.
    Type: Application
    Filed: May 17, 2013
    Publication date: May 21, 2015
    Inventors: Rasmus Joergensen, Soeren Oestergaard, Lars Ynddal, Flemming Seier Nielsen
  • Publication number: 20130345134
    Abstract: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
    Type: Application
    Filed: December 16, 2011
    Publication date: December 26, 2013
    Applicant: NOVO NORDISK A/S
    Inventors: Per Sauerberg, Simon Bjerregaard, Flemming Seier Nielsen